#usph
Latest news and interesting information about usph.
Stifel Initiates Eupraxia with Buy Rating
Stifel initiated coverage on Eupraxia Pharmaceuticals with a Buy rating and $25 target. Diffusphere platform and strong finances highlighted.
USPH shareholders approve all proposals
USPH shareholders approve all proposals at annual meeting, including director elections, executive compensation, and auditor ratification.
...

